logo-loader
NASDAQ:NTRP

Neurotrope

Receive alerts
Market:
NASDAQ
Market Cap:
$73.18 m
Price
$5.62
Change
-3.60%
52 weeks high
9.50
52 weeks low
3.34

In brief

Neurotrope operates as a clinical-stage biopharmaceutical and diagnostics company. Its two product platforms include a minimally-invasive diagnostic test for Alzheimer's disease and a drug candidate, known as bryostatin for the treatment of Alzheimer's disease, both of which are in the clinical testing stage.